Cardlytics

$119.33
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$3.79 (-3.08%) Today
$0.00 (0.00%) As of 10:00 PM UTC after-hours

Why Robinhood?

You can buy or sell Cardlytics and other stocks, options, and ETFs commission-free!

About CDLX

Cardlytics, Inc. engages in the development of marketing solutions through its purchase intelligence platform. It operates through the Cardlytics Direct and Other Platform Solutions segments. The Cardlytics Direct segment represents its proprietary native bank advertising channel. The Other Platform Solutions segment includes solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded by Scott D. Grimes, Lynne M. Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA. The listed name for CDLX is Cardlytics, Inc. Common Stock.

CEO
Lynne Marie Laube
Employees
432
Headquarters
Atlanta, Georgia
Founded
2008
Market Cap
3.28B
Price-Earnings Ratio
Dividend Yield
Average Volume
407.76K
High Today
$124.12
Low Today
$118.30
Open Price
$123.11
Volume
305.96K
52 Week High
$125.50
52 Week Low
$27.33

Collections

CDLX News

MarketWatchNov 26

How the pandemic presented a stock-market opportunity to Sen. David Perdue of Georgia

WASHINGTON (AP) — As the ravages of the novel coronavirus forced millions of people out of work, shuttered businesses and shrank the value of retirement account

CDLX Earnings

-$0.47
-$0.25
-$0.04
$0.18
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 2, After Hours

You May Also Like